Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
$5.28 -0.24 (-4.26%)
As of 01:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ACB vs. ETNB, AUPH, GYRE, MLYS, WVE, PAHC, ARDX, COLL, NTLA, and RCUS

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include 89bio (ETNB), Aurinia Pharmaceuticals (AUPH), Gyre Therapeutics (GYRE), Mineralys Therapeutics (MLYS), Wave Life Sciences (WVE), Phibro Animal Health (PAHC), Ardelyx (ARDX), Collegium Pharmaceutical (COLL), Intellia Therapeutics (NTLA), and Arcus Biosciences (RCUS). These companies are all part of the "pharmaceutical products" industry.

Aurora Cannabis vs.

Aurora Cannabis (NASDAQ:ACB) and 89bio (NASDAQ:ETNB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Aurora Cannabis has higher revenue and earnings than 89bio. 89bio is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$320.81M0.97-$48.62M$0.05110.40
89bioN/AN/A-$142.19M-$3.38-2.90

47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 2.6% of 89bio shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, 89bio had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 11 mentions for 89bio and 3 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.19 beat 89bio's score of 0.90 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
89bio
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89bio has a consensus target price of $26.43, suggesting a potential upside of 169.40%. Given 89bio's higher probable upside, analysts plainly believe 89bio is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67
89bio
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
3.00

Aurora Cannabis has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500. Comparatively, 89bio has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.

Aurora Cannabis received 269 more outperform votes than 89bio when rated by MarketBeat users. However, 61.83% of users gave 89bio an outperform vote while only 59.63% of users gave Aurora Cannabis an outperform vote.

CompanyUnderperformOutperform
Aurora CannabisOutperform Votes
384
59.63%
Underperform Votes
260
40.37%
89bioOutperform Votes
115
61.83%
Underperform Votes
71
38.17%

Aurora Cannabis has a net margin of 0.42% compared to 89bio's net margin of 0.00%. Aurora Cannabis' return on equity of 0.59% beat 89bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis0.42% 0.59% 0.42%
89bio N/A -59.58%-52.21%

Summary

Aurora Cannabis beats 89bio on 12 of the 17 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$310.30M$1.23B$5.38B$8.47B
Dividend YieldN/AN/A5.28%4.17%
P/E Ratio110.4211.8326.9919.79
Price / Sales0.979.85412.17137.59
Price / Cash26.3510.4038.2534.64
Price / Book0.671.516.844.53
Net Income-$48.62M-$56.07M$3.22B$247.85M
7 Day Performance0.36%5.27%2.47%2.44%
1 Month Performance18.97%4.05%9.71%10.64%
1 Year Performance-10.24%-32.21%20.95%10.45%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.5613 of 5 stars
$5.29
-4.3%
N/A-10.5%$297.09M$320.81M105.721,340Positive News
ETNB
89bio
2.3975 of 5 stars
$7.70
-1.0%
$26.43
+243.2%
+22.3%$1.12BN/A-2.6540Positive News
AUPH
Aurinia Pharmaceuticals
3.3847 of 5 stars
$8.07
-1.5%
$11.50
+42.5%
+54.8%$1.09B$247.30M-53.80300Positive News
GYRE
Gyre Therapeutics
0.1222 of 5 stars
$11.11
-2.1%
N/A-4.9%$1.04B$100.64M555.5040News Coverage
Gap Up
MLYS
Mineralys Therapeutics
2.9913 of 5 stars
$15.32
-0.2%
$38.00
+148.0%
+27.2%$998.48MN/A-4.2128
WVE
Wave Life Sciences
4.3604 of 5 stars
$6.46
+2.1%
$21.17
+227.7%
+4.0%$995.71M$104.94M-5.82240Positive News
PAHC
Phibro Animal Health
3.6673 of 5 stars
$24.13
+0.5%
$20.00
-17.1%
+35.9%$978.09M$1.19B50.271,860Positive News
ARDX
Ardelyx
4.6321 of 5 stars
$4.06
+4.6%
$10.39
+155.9%
-39.0%$971.38M$361.71M-25.3890
COLL
Collegium Pharmaceutical
4.0407 of 5 stars
$29.83
-1.3%
$43.80
+46.8%
-12.1%$958.50M$664.28M12.86210Positive News
NTLA
Intellia Therapeutics
4.6125 of 5 stars
$9.06
+6.6%
$36.90
+307.3%
-65.6%$938.46M$45.57M-1.67600Trending News
Analyst Forecast
High Trading Volume
RCUS
Arcus Biosciences
2.5614 of 5 stars
$8.70
+1.6%
$25.67
+195.0%
-37.3%$921.20M$141M-2.76500Short Interest ↑

Related Companies and Tools


This page (NASDAQ:ACB) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners